Archive for the 'HIV Patients' Category
Drugs Available in the United Kingdom Extend Life of HIV Patients
Over the last ten years of researching better treatments for HIV patients, eventually a new drug had been found in Great Britain to lengthen the life expectancy of the victims. The recent medication of Pfizer’s pharmacy - Celsentri (Maraviroc) is an effective treatment truly helpful for the patients, which works by guarding the entrance of the immune system and blocks the HIV, as a result delays the process of developing into AIDS. Although the drug is not a cure-all treatment, this is an alternative that patients can look forward to since not all symptoms are remedied by other available HIV drugs in the market. Many AIDS organizations have been interested in this medication saying this is a good sign of innovation and will help to reduce the progression of HIV into AIDS.
Three medications have been comprised by Maraviroc that collectively made into one creating highly active anti-retroviral therapy (HAART) that lengthens the lifespan of HIV patients. However, recent researches indicated that some patients have resistance to the product making it not advisable for them to take. The drug was approved in August for public use in the United States under the brand name Selzentry. The drug is taken orally in combination with the other anti-retroviral drugs.
The drug’s mode of action works as it becomes a microscopic blockade of the CCR5 receptor, which the HIV virus usually strikes, as it enters the immune system particularly the CD4-T-cells. When the cell receptor is blocked, it makes the body more resistant to infection of the cells and slows down the process of developing the virus into full-blown AIDS. As this happens, complications are being delayed making the HIV-positive patients to live longer.
No comments